Detection of Pseudomonas aeruginosa in cystic fibrosis after initiation of CFTR modulators: a systematic review
Paediatric Respiratory Reviews · 2026
DOI: 10.1016/j.prrv.2026.01.004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Paediatric Respiratory Reviews, 2026. Verfasst von Vito Terlizzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Meyer Children's Hospital, IRCCS, Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Florence, Italy. Electronic address: …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Pseudomonas aeruginosa remains a major cause of morbidity in people with cystic fibrosis (pwCF). The advent of elexacaftor/tezacaftor/ivacaftor (ETI) has transformed clinical outcomes, but its impact on airway microbiology and diagnostic surveillance remains uncertain. We conducted a systematic review of PubMed and Embase (2019-2025) according to PRISMA guidelines, including studies comparing culture with molecular methods for P. aeruginosa detection in pwCF treated with ETI. Fourteen observational studies (n=2525 subjects) were identified. Chronic P. aeruginosa detection declined from 51.4% at baseline to 24.8% after ETI, with nearly half of colonized subjects achieving apparent clearance. Several studies applying molecular techniques reported persistent P. aeruginosa detection despite negative cultures. These findings indicate that ETI markedly reduces bacterial burden and sputum availability, which may limit the sensitivity of culture-based surveillance. However, the clinical and inflammatory significance of PCR+/culture- results remains uncertain. Combining molecular and culture-based surveillance may help guide infection monitoring in the modulator era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meyer Children's Hospital, IRCCS, Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Florence, Italy. Electronic address: vito.terlizzi@meyer.it.
- Department of Health Sciences, Postgraduate School of Pediatrics, University of Florence, Florence, Italy.
- Meyer Children's Hospital, IRCCS, Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Florence, Italy.
- Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy; Department of Health Sciences, University of Florence, Viale Pieraccini 24, 50139 Firenze, Italy. Electronic address: elena.chiappini@unifi.it.
Zitieren
APA
Terlizzi, V., Timitilli, E., Fiumara, M. S., Dolce, D., Campana, S., & Chiappini, E. (2026). Detection of Pseudomonas aeruginosa in cystic fibrosis after initiation of CFTR modulators: a systematic review. Paediatric Respiratory Reviews. https://doi.org/10.1016/j.prrv.2026.01.004
Vancouver
Terlizzi V, Timitilli E, Fiumara MS, Dolce D, Campana S, Chiappini E. Detection of Pseudomonas aeruginosa in cystic fibrosis after initiation of CFTR modulators: a systematic review. Paediatric Respiratory Reviews. 2026. doi:10.1016/j.prrv.2026.01.004
BibTeX
@article{Terlizzi2026,
author = {Terlizzi, Vito and Timitilli, Edoardo and Fiumara, Maria Sole and Dolce, Daniela and Campana, Silvia and Chiappini, Elena},
title = {Detection of Pseudomonas aeruginosa in cystic fibrosis after initiation of CFTR modulators: a systematic review},
journal = {Paediatric Respiratory Reviews},
year = {2026},
doi = {10.1016/j.prrv.2026.01.004}
}
EUVIMED